FBRX – Forte Biosciences Inc
FBRX
$14.41Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $179,157,424.00
EPSttm : -3.68
Forte Biosciences, Inc.
$14.41
Float Short %
1.06
Margin Of Safety %
Put/Call OI Ratio
75
EPS Next Q Diff
-0.08
EPS Last/This Y
7.74
EPS This/Next Y
1.11
Price
14.18
Target Price
52.25
Analyst Recom
1
Performance Q
14.02
Relative Volume
0.69
Beta
3
Ticker: FBRX
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-09-08 | FBRX | 10.99 | 112.00 | 999.99 | 226 |
2025-09-09 | FBRX | 11.07 | 112.00 | 999.99 | 226 |
2025-09-10 | FBRX | 10.94 | 112.00 | 999.99 | 226 |
2025-09-11 | FBRX | 10.48 | 112.00 | 999.99 | 226 |
2025-09-12 | FBRX | 10.52 | N/A | N/A | 0 |
2025-09-15 | FBRX | 11.43 | 112.50 | 0.00 | 227 |
2025-09-16 | FBRX | 12.31 | 75.00 | 999.99 | 228 |
2025-09-17 | FBRX | 11.96 | 75.333333333333 | 999.99 | 229 |
2025-09-18 | FBRX | 13.07 | 75.33 | 999.99 | 229 |
2025-09-19 | FBRX | 13.65 | 75.33 | 999.99 | 229 |
2025-09-22 | FBRX | 14.85 | 1.00 | 999.99 | 4 |
2025-09-23 | FBRX | 15.98 | 1.00 | 999.99 | 4 |
2025-09-24 | FBRX | 14.94 | 58.50 | 999.99 | 119 |
2025-09-25 | FBRX | 14.12 | 69.50 | 999.99 | 141 |
2025-09-26 | FBRX | 13.61 | 69.50 | 999.99 | 141 |
2025-09-29 | FBRX | 14.51 | 69.50 | 999.99 | 141 |
2025-09-30 | FBRX | 14.9 | 69.50 | 999.99 | 141 |
2025-10-01 | FBRX | 14.51 | 69.50 | 999.99 | 141 |
2025-10-02 | FBRX | 13.43 | 69.50 | 999.99 | 141 |
2025-10-03 | FBRX | 15.48 | 69.50 | 999.99 | 141 |
2025-10-06 | FBRX | 14.4 | 75.00 | 0.10 | 152 |
2025-10-07 | FBRX | 14.17 | 75.00 | 0.10 | 152 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-09-08 | FBRX | 11.13 | 76.5 | - | -4.43 |
2025-09-09 | FBRX | 10.91 | 76.5 | - | -4.43 |
2025-09-10 | FBRX | 10.93 | 76.5 | - | -4.43 |
2025-09-11 | FBRX | 10.46 | 76.5 | - | -4.43 |
2025-09-12 | FBRX | 10.56 | 76.5 | - | -4.43 |
2025-09-15 | FBRX | 11.48 | 76.5 | - | -4.43 |
2025-09-16 | FBRX | 12.33 | 76.5 | - | -4.43 |
2025-09-17 | FBRX | 11.93 | 76.5 | - | -4.43 |
2025-09-18 | FBRX | 13.21 | 76.5 | - | -4.43 |
2025-09-19 | FBRX | 13.64 | 76.5 | - | -4.43 |
2025-09-22 | FBRX | 14.78 | 76.5 | - | -4.43 |
2025-09-23 | FBRX | 15.98 | 76.5 | - | -4.43 |
2025-09-24 | FBRX | 14.99 | 76.5 | - | -4.43 |
2025-09-25 | FBRX | 14.25 | 76.5 | - | -4.43 |
2025-09-26 | FBRX | 13.84 | 76.5 | - | -4.43 |
2025-09-29 | FBRX | 14.40 | 76.5 | - | -4.43 |
2025-09-30 | FBRX | 14.94 | 76.5 | - | -4.43 |
2025-10-01 | FBRX | 14.50 | 76.5 | - | -4.43 |
2025-10-02 | FBRX | 13.23 | 76.5 | - | -4.43 |
2025-10-03 | FBRX | 15.48 | 76.5 | - | -4.43 |
2025-10-06 | FBRX | 14.60 | 76.5 | - | -4.43 |
2025-10-07 | FBRX | 14.18 | 76.5 | - | -4.43 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-09-08 | FBRX | 0.00 | 360.08 | 0.96 |
2025-09-09 | FBRX | 0.00 | 360.08 | 0.96 |
2025-09-10 | FBRX | 0.00 | 360.08 | 0.96 |
2025-09-11 | FBRX | 0.00 | 360.08 | 0.93 |
2025-09-12 | FBRX | 0.00 | 360.08 | 0.93 |
2025-09-15 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-16 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-17 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-18 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-19 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-22 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-23 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-24 | FBRX | 0.00 | 182.92 | 0.93 |
2025-09-25 | FBRX | 0.00 | 182.92 | 1.06 |
2025-09-26 | FBRX | 0.00 | 182.92 | 1.06 |
2025-09-29 | FBRX | 0.00 | 182.92 | 1.06 |
2025-09-30 | FBRX | 0.00 | 182.92 | 1.06 |
2025-10-01 | FBRX | 0.00 | 182.92 | 1.06 |
2025-10-02 | FBRX | 0.00 | 182.92 | 1.06 |
2025-10-03 | FBRX | 0.00 | 182.92 | 1.06 |
2025-10-06 | FBRX | 0.00 | 42.23 | 1.06 |
2025-10-07 | FBRX | 0.00 | 42.23 | 1.06 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.96
Avg. EPS Est. Current Quarter
-1.07
Avg. EPS Est. Next Quarter
-1.04
Insider Transactions
Institutional Transactions
42.23
Beta
3
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
19
Sentiment Score
68
Actual DrawDown %
98.8
Max Drawdown 5-Year %
-99.6
Target Price
52.25
P/E
Forward P/E
PEG
P/S
P/B
1.77
P/Free Cash Flow
EPS
-7.99
Average EPS Est. Cur. Y
-4.43
EPS Next Y. (Est.)
-3.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.69
Return on Equity vs Sector %
-68.2
Return on Equity vs Industry %
-54.5
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.05
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 17
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading